Search

Your search keyword '"Planchamp, François"' showing total 158 results
Start Over Author "Planchamp, François"
158 results on '"Planchamp, François"'

1. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*

Author

Cibula, David, Raspollini, Maria Rosaria, Planchamp, François, Centeno, Carlos, Chargari, Cyrus, Felix, Ana, Fischerová, Daniela, Jahnn-Kuch, Daniela, Joly, Florence, Kohler, Christhardt, Lax, Sigurd, Lorusso, Domenica, Mahantshetty, Umesh, Mathevet, Patrice, Naik, Raj, Nout, Remi A., Oaknin, Ana, Peccatori, Fedro, Persson, Jan, Querleu, Denis, Bernabé, Sandra Rubio, Schmid, Maximilian P., Stepanyan, Artem, Svintsitskyi, Valentyn, Tamussino, Karl, Zapardiel, Ignacio, and Lindegaard, Jacob

Published
2023
Full Text
View/download PDF

4. European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management

Author

Fotopoulou, Christina, primary, Eriksson, Ane Gerda, additional, Planchamp, François, additional, Morice, Philippe, additional, Taylor, Alexandra, additional, Sturdza, Alina, additional, Florin Coza, Ovidiu, additional, Halaska, Michael J, additional, Martinelli, Fabio, additional, Armbrust, Robert, additional, and Chargari, Cyrus, additional

Published
2024
Full Text
View/download PDF

5. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions

Author

Preti, Mario, Joura, Elmar, Vieira-Baptista, Pedro, Van Beurden, Marc, Bevilacqua, Federica, Bleeker, Maaike C G, Bornstein, Jacob, Carcopino, Xavier, Chargari, Cyrus, Cruickshank, Margaret E, Erzeneoglu, Bilal Emre, Gallio, Niccolò, Heller, Debra, Kesic, Vesna, Reich, Olaf, Stockdale, Colleen K, Temiz, Bilal Esat, Woelber, Linn, Planchamp, François, Zodzika, Jana, Querleu, Denis, and Gultekin, Murat

Published
2022
Full Text
View/download PDF

6. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

Author

Concin, Nicole, Creutzberg, Carien L., Vergote, Ignace, Cibula, David, Mirza, Mansoor Raza, Marnitz, Simone, Ledermann, Jonathan A., Bosse, Tjalling, Chargari, Cyrus, Fagotti, Anna, Fotopoulou, Christina, González-Martín, Antonio, Lax, Sigurd F., Lorusso, Domenica, Marth, Christian, Morice, Philippe, Nout, Remi A., O’Donnell, Dearbhaile E., Querleu, Denis, Raspollini, Maria Rosaria, Sehouli, Jalid, Sturdza, Alina E., Taylor, Alexandra, Westermann, Anneke M., Wimberger, Pauline, Colombo, Nicoletta, Planchamp, François, and Matias-Guiu, Xavier

Published
2021
Full Text
View/download PDF

10. Texte court rédigé à partir de la recommandation nationale de bonnes pratiques cliniques « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l’INCa »

Author

Lavoue, Vincent, Huchon, Cyrille, Akladios, Cherif, Alfonsi, Pascal, Bakrin, Naoual, Ballester, Marcos, Bendifallah, Sofiane, Bolze, Pierre-Adrien, Bonnet, Fabrice, Bourgin, Charlotte, Chabbert-Buffet, Nathalie, Collinet, Pierre, Courbiere, Blandine, De la Motte Rouge, Thibault, Devouassoux-Shisheboran, Mojgan, Falandry, Claire, Ferron, Gwenal, Fournier, Laure, Gladieff, Laurence, Golfier, François, Gouy, Sébastien, Guyon, Frédérique, Lambaudie, Eric, Leary, Alexandra, Lecuru, Fabrice, Lefrere-Belda, Marie-Aude, Leblanc, Eric, Lemoine, Adrien, Narducci, Fabrice, Ouldamer, Lobna, Pautier, Patricia, Planchamp, François, Pouget, Nicolas, Ray-Coquard, Isabelle, Rousset-Jablonski, Christine, Senechal-Davin, Claire, Touboul, Cyril, Thomassin-Naggara, Isabelle, Uzan, Catherine, You, Benoit, and Daraï, Emile

Published
2019
Full Text
View/download PDF

11. Response to: Correspondence on 'ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors' by Thomassin-Nagarra et al

Author

Timmerman, Dirk, Cibula, David, Planchamp, François, Bourne, Tom, Landolfo, Chiara, Testa, Antonia Carla, du Bois, Andreas, Chiva, Luis, Concin, Nicole, fisherova, Daniela, Froyman, Wouter, Lemley, Birthe, Loft, Annika, Mereu, Liliana, Morice, Philippe, Querleu, Denis, Vergote, Ignace, Vandecaveye, Vincent, Scambia, Giovanni, and Fotopoulou, Christina

Published
2021
Full Text
View/download PDF

12. European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery

Author

Fotopoulou, Christina, Planchamp, François, Aytulu, Tugce, Chiva, Luis, Cina, Alessandro, Ergönül, Önder, Fagotti, Anna, Haidopoulos, Dimitrios, Hasenburg, Annette, Hughes, Cathy, Knapp, Pawel, Morice, Philippe, Schneider, Stephanie, Sehouli, Jalid, Stamatakis, Emmanouil, Suria, Stephanie, Taskiran, Cagatay, Trappe, Ralf Ulrich, and Campbell, Jeremy

Published
2021
Full Text
View/download PDF

13. ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

Author

Timmerman, Dirk, Planchamp, François, Bourne, Tom, Landolfo, Chiara, du Bois, Andreas, Chiva, Luis, Cibula, David, Concin, Nicole, Fischerova, Daniela, Froyman, Wouter, Madueño, Guillermo Gallardo, Lemley, Birthe, Loft, Annika, Mereu, Liliana, Morice, Philippe, Querleu, Denis, Testa, Antonia Carla, Vergote, Ignace, Vandecaveye, Vincent, Scambia, Giovanni, and Fotopoulou, Christina

Published
2021
Full Text
View/download PDF

14. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023

Author

Cibula, David, primary, Rosaria Raspollini, Maria, additional, Planchamp, François, additional, Centeno, Carlos, additional, Chargari, Cyrus, additional, Felix, Ana, additional, Fischerová, Daniela, additional, Jahnn-Kuch, Daniela, additional, Joly, Florence, additional, Kohler, Christhardt, additional, Lax, Sigurd, additional, Lorusso, Domenica, additional, Mahantshetty, Umesh, additional, Mathevet, Patrice, additional, Raj Naik, Mr, additional, Nout, Remi A, additional, Oaknin, Ana, additional, Peccatori, Fedro, additional, Persson, Jan, additional, Querleu, Denis, additional, Rubio Bernabé, Sandra, additional, Schmid, Maximilian P., additional, Stepanyan, Artem, additional, Svintsitskyi, Valentyn, additional, Tamussino, Karl, additional, Zapardiel, Ignacio, additional, and Lindegaard, Jacob Christian, additional

Published
2023
Full Text
View/download PDF

15. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023

Author

Oonk, Maaike H M, primary, Planchamp, François, additional, Baldwin, Peter, additional, Mahner, Sven, additional, Mirza, Mansoor Raza, additional, Fischerová, Daniela, additional, Creutzberg, Carien L, additional, Guillot, Eugénie, additional, Garganese, Giorgia, additional, Lax, Sigurd, additional, Redondo, Andres, additional, Sturdza, Alina, additional, Taylor, Alexandra, additional, Ulrikh, Elena, additional, Vandecaveye, Vincent, additional, van der Zee, Ate, additional, Wölber, Linn, additional, Zach, Diana, additional, Zannoni, Gian Franco, additional, and Zapardiel, Ignacio, additional

Published
2023
Full Text
View/download PDF

16. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer

Author

Cibula, David, Pötter, Richard, Planchamp, François, Avall-Lundqvist, Elisabeth, Fischerova, Daniela, Haie Meder, Christine, Köhler, Christhardt, Landoni, Fabio, Lax, Sigurd, Lindegaard, Jacob Christian, Mahantshetty, Umesh, Mathevet, Patrice, McCluggage, W. Glenn, McCormack, Mary, Naik, Raj, Nout, Remi, Pignata, Sandro, Ponce, Jordi, Querleu, Denis, Raspagliesi, Francesco, Rodolakis, Alexandros, Tamussino, Karl, Wimberger, Pauline, and Raspollini, Maria Rosaria

Published
2018
Full Text
View/download PDF

17. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer

Author

Chargari, Cyrus, primary, Tanderup, Kari, additional, Planchamp, François, additional, Chiva, Luis, additional, Humphrey, Pauline, additional, Sturdza, Alina, additional, Tan, Li T, additional, van der Steen-Banasik, Elzbieta, additional, Zapardiel, Ignacio, additional, Nout, Remi A, additional, and Fotopoulou, Christina, additional

Published
2023
Full Text
View/download PDF

18. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial Neoplasia

Author

Kesic, Vesna, primary, Carcopino, Xavier, additional, Preti, Mario, additional, Vieira-Baptista, Pedro, additional, Bevilacqua, Federica, additional, Bornstein, Jacob, additional, Chargari, Cyrus, additional, Cruickshank, Maggie, additional, Erzeneoglu, Emre, additional, Gallio, Niccolò, additional, Gultekin, Murat, additional, Heller, Debra, additional, Joura, Elmar, additional, Kyrgiou, Maria, additional, Madić, Tatjana, additional, Planchamp, François, additional, Regauer, Sigrid, additional, Reich, Olaf, additional, Esat Temiz, Bilal, additional, Woelber, Linn, additional, Zodzika, Jana, additional, and Stockdale, Colleen, additional

Published
2023
Full Text
View/download PDF

22. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma

Author

Rodolakis, Alexandros, primary, Scambia, Giovanni, additional, Planchamp, François, additional, Acien, Maribel, additional, Di Spiezio Sardo, Attilio, additional, Farrugia, Martin, additional, Grynberg, Michael, additional, Pakiz, Maja, additional, Pavlakis, Kitty, additional, Vermeulen, Nathalie, additional, Zannoni, Gianfranco, additional, Zapardiel, Ignacio, additional, and Macklon, Kirsten Louise Tryde, additional

Published
2023
Full Text
View/download PDF

23. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma,

Author

Rodolakis, Alexandros, primary, Scambia, Giovanni, additional, Planchamp, François, additional, Acien, Maribel, additional, Di Spiezio Sardo, Attilio, additional, Farrugia, Martin, additional, Grynberg, Michael, additional, Pakiz, Maja, additional, Pavlakis, Kitty, additional, Vermeulen, Nathalie, additional, Zannoni, Gianfranco, additional, Zapardiel, Ignacio, additional, and Macklon, Kirsten Louise Tryde, additional

Published
2022
Full Text
View/download PDF

26. How to improve adherence of guidelines for localized testicular cancer surveillance: A Delphi consensus study

Author

Da Silva, Angélique, primary, Fléchon, Aude, additional, Coquan, Elodie, additional, Planchamp, François, additional, Culine, Stéphane, additional, Murez, Thibaut, additional, Méjean, Arnaud, additional, Pasquier, David, additional, Chevreau, Christine, additional, Fizazi, Karim, additional, Thiery-Vuilemin, Antoine, additional, and Joly, Florence, additional

Published
2022
Full Text
View/download PDF

27. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions

Author

Preti, Mario, primary, Joura, Elmar, additional, Vieira-Baptista, Pedro, additional, Van Beurden, Marc, additional, Bevilacqua, Federica, additional, Bleeker, Maaike C. G., additional, Bornstein, Jacob, additional, Carcopino, Xavier, additional, Chargari, Cyrus, additional, Cruickshank, Margaret E., additional, Erzeneoglu, Bilal Emre, additional, Gallio, Niccolò, additional, Heller, Debra, additional, Kesic, Vesna, additional, Reich, Olaf, additional, Stockdale, Colleen K., additional, Temiz, Bilal Esat, additional, Woelber, Linn, additional, Planchamp, François, additional, Zodzika, Jana, additional, Querleu, Denis, additional, and Gultekin, Murat, additional

Published
2022
Full Text
View/download PDF

28. European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

Author

Querleu, Denis, Planchamp, François, Chiva, Luis, Fotopoulou, Christina, Barton, Desmond, Cibula, David, Aletti, Giovanni, Carinelli, Silvestro, Creutzberg, Carien, Davidson, Ben, Harter, Philip, Lundvall, Lene, Marth, Christian, Morice, Philippe, Rafii, Arash, Ray-Coquard, Isabelle, Rockall, Andrea, Sessa, Christiana, van der Zee, Ate, Vergote, Ignace, and duBois, Andreas

Published
2017
Full Text
View/download PDF

29. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus...

Author

Kesic, Vesna, Carcopino, Xavier, Preti, Mario, Vieira-Baptista, Pedro, Bevilacqua, Federica, Bornstein, Jacob, Chargari, Cyrus, Cruickshank, Maggie, Erzeneoglu, Emre, Gallio, Niccolò, Gultekin, Murat, Heller, Debra, Joura, Elmar, Kyrgiou, Maria, Madić, Tatjana, Planchamp, François, Regauer, Sigrid, Reich, Olaf, Temiz, Bilal Esat, and Woelber, Linn

Published
2023
Full Text
View/download PDF

30. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma,.

Author

Rodolakis, Alexandros, Scambia, Giovanni, Planchamp, François, Acien, Maribel, Sardo, Attilio Di Spiezio, Farrugia, Martin, Grynberg, Michael, Pakiz, Maja, Pavlakis, Kitty, Vermeulen, Nathalie, Zannoni, Gianfranco, Zapardiel, Ignacio, and Macklon, Kirsten Louise Tryde

Subjects
TREATMENT of endometrial cancer, FOLLOW-up studies (Medicine), FERTILITY preservation
Abstract

STUDY QUESTION How should fertility-sparing treatment of patients with endometrial carcinoma be performed? SUMMARY ANSWER Forty-eight recommendations were formulated on fertility-sparing treatment of patients with endometrial carcinoma. WHAT IS KNOWN ALREADY The standard surgical treatment of endometrial carcinoma consisting of total hysterectomy with bilateral salpingo-oophorectomy drastically affects the quality of life of patients and creates a challenge for clinicians. Recent evidence-based guidelines of the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) provide comprehensive guidelines on all relevant issues of diagnosis and treatment in endometrial carcinoma in a multidisciplinary setting. While addressing also work-up for fertility preservation treatments and the management and follow-up for fertility preservation, it was considered relevant to further extend the guidance on fertility-sparing treatment. STUDY DESIGN, SIZE, DURATION A collaboration was set up between the ESGO, the European Society of Human Reproduction and Embryology (ESHRE) and the European Society for Gynaecological Endoscopy (ESGE), aiming to develop clinically relevant and evidence-based guidelines focusing on key aspects of fertility-sparing treatment in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide. PARTICIPANTS/MATERIALS, SETTING, METHODS ESGO/ESHRE/ESGE nominated an international multidisciplinary development group consisting of practising clinicians and researchers who have demonstrated leadership and expertise in the care and research of endometrial carcinoma (11 experts across Europe). To ensure that the guidelines are evidence-based, the literature published since 2016, identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgement was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 95 independent international practitioners in cancer care delivery and patient representatives. MAIN RESULTS AND THE ROLE OF CHANCE The multidisciplinary development group formulated 48 recommendations in four sections; patient selection, tumour clinicopathological characteristics, treatment and special issues. LIMITATIONS, REASONS FOR CAUTION Of the 48 recommendations, none could be based on level I evidence and only 16 could be based on level II evidence, implicating that 66% of the recommendations are supported only by observational data, professional experience and consensus of the development group. WIDER IMPLICATIONS OF THE FINDINGS These recommendations provide guidance to professionals caring for women with endometrial carcinoma, including but not limited to professionals in the field of gynaecological oncology, onco-fertility, reproductive surgery, endoscopy, conservative surgery and histopathology, and will help towards a holistic and multidisciplinary approach for this challenging clinical scenario. STUDY FUNDING/COMPETING INTEREST(S) All costs relating to the development process were covered from ESGO, ESHRE and ESGE funds. There was no external funding of the development process or manuscript production. G.S. has reported grants from MSD Italia S.r.l. advisory boards for Storz, Bayer, Astrazeneca, Metronic, TESARO Bio Italy S.r.l and Johnson & Johnson, and honoraria for lectures from Clovis Oncology Italy S.r.l. M.G. has reported advisory boards for Gedeon Richter and Merck. The other authors have reported no conflicts of interest. DISCLAIMER This document represents the views of ESHRE, ESGO and ESGE which are the result of consensus between the relevant stakeholders and where relevant based on the scientific evidence available at the time of preparation. The recommendations should be used for informational and educational purposes. They should not be interpreted as setting a standard of care, or be deemed inclusive of all proper methods of care nor exclusive of other methods of care reasonably directed to obtaining the same results. They do not replace the need for application of clinical judgement to each individual presentation, nor variations based on locality and facility type. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

31. Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer

Author

Cibula, David, Pötter, Richard, Planchamp, François, Avall-Lundqvist, Elisabeth, Fischerova, Daniela, Haie-Meder, Christine, Köhler, Christhardt, Landoni, Fabio, Lax, Sigurd, Lindegaard, Jacob Christian, Mahantshetty, Umesh, Mathevet, Patrice, McCluggage, W. Glenn, McCormack, Mary, Naik, Raj, Nout, Remi, Pignata, Sandro, Ponce, Jordi, Querleu, Denis, Raspagliesi, Francesco, Rodolakis, Alexandros, Tamussino, Karl, Wimberger, Pauline, and Raspollini, Maria Rosaria

Published
2018
Full Text
View/download PDF

32. Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer

Author

Cibula, David, Pötter, Richard, Planchamp, François, Avall-Lundqvist, Elisabeth, Fischerova, Daniela, Haie-Meder, Christine, Köhler, Christhardt, Landoni, Fabio, Lax, Sigurd, Lindegaard, Jacob Christian, Mahantshetty, Umesh, Mathevet, Patrice, Glenn McCluggage, W., McCormack, Mary, Naik, Raj, Nout, Remi, Pignata, Sandro, Ponce, Jordi, Querleu, Denis, Raspagliesi, Francesco, Rodolakis, Alexandros, Tamussino, Karl, Wimberger, Pauline, and Raspollini, Maria Rosaria

Published
2018
Full Text
View/download PDF

34. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Author

Concin, Nicole, primary, Matias-Guiu, Xavier, additional, Vergote, Ignace, additional, Cibula, David, additional, Mirza, Mansoor Raza, additional, Marnitz, Simone, additional, Ledermann, Jonathan, additional, Bosse, Tjalling, additional, Chargari, Cyrus, additional, Fagotti, Anna, additional, Fotopoulou, Christina, additional, Martin, Antonio Gonzalez, additional, Lax, Sigurd, additional, Lorusso, Domenica, additional, Marth, Christian, additional, Morice, Philippe, additional, Nout, Remi A., additional, O'Donnell, Dearbhaile, additional, Querleu, Denis, additional, Raspollini, Maria Rosaria, additional, Sehouli, Jalid, additional, Sturdza, Alina, additional, Taylor, Alexandra, additional, Westermann, Anneke, additional, Wimberger, Pauline, additional, Colombo, Nicoletta, additional, Planchamp, François, additional, and Creutzberg, Carien L., additional

Published
2021
Full Text
View/download PDF

35. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Author

Concin, Nicole, primary, Matias-Guiu, Xavier, additional, Vergote, Ignace, additional, Cibula, David, additional, Mirza, Mansoor Raza, additional, Marnitz, Simone, additional, Ledermann, Jonathan, additional, Bosse, Tjalling, additional, Chargari, Cyrus, additional, Fagotti, Anna, additional, Fotopoulou, Christina, additional, Gonzalez Martin, Antonio, additional, Lax, Sigurd, additional, Lorusso, Domenica, additional, Marth, Christian, additional, Morice, Philippe, additional, Nout, Remi A, additional, O'Donnell, Dearbhaile, additional, Querleu, Denis, additional, Raspollini, Maria Rosaria, additional, Sehouli, Jalid, additional, Sturdza, Alina, additional, Taylor, Alexandra, additional, Westermann, Anneke, additional, Wimberger, Pauline, additional, Colombo, Nicoletta, additional, Planchamp, François, additional, and Creutzberg, Carien L, additional

Published
2020
Full Text
View/download PDF

39. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]

Author

Rousset-Jablonski, Christine, Selle, Frédéric, Adda-Herzog, Elodie, Planchamp, François, Selleret, Lise, Pomel, Christophe, Chabbert-Buffet, Nathalie, Darai, Emile, Pautier, Patricia, Trémollières, Florence, Guyon, Frédéric, Rouzier, Roman, Laurence, Valérie, Chopin, Nicolas, Faure-Conter, Cécile, Bentivegna, Enrica, Vacher-Lavenu, Marie-Cécile, Lhomme, Catherine, Floquet, Anne, Treilleux, Isabelle, Lecuru, Fabrice, Gouy, Sébastien, Kalbacher, Elsa, Genestie, Catherine, de La Motte Rouge, Thibault, Ferron, Gwenaël, Devouassoux-Shisheboran, Mojgan, Kurtz, Jean-Emmanuel, Namer, Moïse, Joly, Florence, Pujade-Lauraine, Eric, Grynberg, Michael, Querleu, Denis, Morice, Philippe, Gompel, Anne, Ray-Coquard, Isabelle, Centre Léon Bérard [Lyon], CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Service d'Oncologie Médicale [CHRU Besançon], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Institut de médecine moléculaire de Rangueil (I2MR), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)- Institut Fédératif de Recherche Bio-médicale Institution (IFR150)-Institut National de la Santé et de la Recherche Médicale (INSERM), Molécules Thérapeutiques in silico (MTI), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), École Nationale de la Statistique et de l'Administration Économique (ENSAE Paris), Institut Gustave Roussy (IGR), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Beninois pour l'Environnement et le développement économique et Social (CEBEDES), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), CHU Pitié-Salpêtrière [AP-HP], Chemistry, Oncogenesis, Stress and Signaling (COSS), Université de Rennes (UR)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Claudius Regaud, Service d'Anatomo-Pathologie [Hôpital de la Croix-Rousse - HCL], Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Les Hôpitaux Universitaires de Strasbourg (HUS), Cancérologie (Inserm U599/IPC), Université de la Méditerranée - Aix-Marseille 2-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Oncologie médicale [CHU Caen], CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Service d'Oncologie Médicale, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Hôpital Hôtel-Dieu [Paris], Unité de Biologie Fonctionnelle et Adaptative (BFA (UMR_8251 / U1133)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Département de chirurgie générale [Gustave Roussy], Unité de Gynécologie, Health Service and Performance Research (HESPER), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon, Alliance Pour la Recherche En Cancérologie [CHU Tenon] (APREC), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Gynécologie-obstétrique et médecine de la reproduction - Maternité [CHU Tenon], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale (INSERM), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'anatomie pathologique [CHU Pitié-Salpêtrière], Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Institut National de la Santé et de la Recherche Médicale (INSERM)-CRLCC Eugène Marquis (CRLCC)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Rennes 1 (UR1), and Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Tumeurs germinales, Fertilité, Delphi Technique, Borderline ovarian tumor, Menopause, Premature, [SDV.CAN]Life Sciences [q-bio]/Cancer, Carcinoma, Ovarian Epithelial, Rare Diseases, Sex cord tumor, Germ cell tumor, Humans, Neoplasms, Glandular and Epithelial, Rare ovarian tumor, Hormone therapy, Ovarian Neoplasms, Contraindications, Drug, Fertility Preservation, Tumeur borderline, Neoplasms, Germ Cell and Embryonal, Traitement hormonal, Contraception, Fertility, Female, Tumeurs des cordons sexuels, Tumeur rare de l’ovaire, Infertility, Female
Abstract

National audience; Introduction - Rare ovarian tumors include complex borderline ovarian tumors, sex-cord tumors, germ cell tumors, and rare epithelial tumors. Indications and modalities of fertility preservation, infertility management and contraindications for hormonal contraception or menopause hormone therapy are frequent issues in clinical practice. A panel of experts from the French national network dedicated to rare gynaecological cancers, and of experts in reproductive medicine and gynaecology have worked on guidelines about fertility preservation, contraception and menopause hormone therapy in women treated for ovarian rare tumors. Methods - A panel of 39 experts from different specialties contributed to the preparation of the guidelines, following the DELPHI method (formal consensus method). Statements were drafted after a systematic literature review, and then rated through two successive rounds. Results - Thirty-five recommendations were selected, and concerned indications for fertility preservation, contraindications for ovarian stimulation (in the context of fertility preservation or for infertility management), contraceptive options (especially hormonal ones), and menopause hormone therapy for each tumor type. Overall, prudence has been recommended in the case of potentially hormone-sensitive tumors such as sex cord tumors, serous and endometrioid low-grade adenocarcinomas, as well as for high-risk serous borderline ovarian tumors. Discussion - In the context of a scarce literature, a formal consensus method allowed the elaboration of guidelines, which will help clinicians in the management of these patients.

Published
2018

40. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers

Author

Rousset-Jablonski, Christine, primary, Selle, Fréderic, additional, Adda-Herzog, Elodie, additional, Planchamp, François, additional, Selleret, Lise, additional, Pomel, Christophe, additional, Daraï, Emile, additional, Chabbert-Buffet, Nathalie, additional, Pautier, Patricia, additional, Trémollières, Florence, additional, Guyon, Frederic, additional, Rouzier, Roman, additional, Laurence, Valérie, additional, Chopin, Nicolas, additional, Faure-Conter, Cécile, additional, Bentivegna, Enrica, additional, Vacher-Lavenu, Marie-Cécile, additional, Lhomme, Catherine, additional, Floquet, Anne, additional, Treilleux, Isabelle, additional, Lecuru, Fabrice, additional, Gouy, Sébastien, additional, Kalbacher, Elsa, additional, Genestie, Catherine, additional, Thibault, de la Motte Rouge, additional, Ferron, Gwenael, additional, Devouassoux, Mojgan, additional, Kurtz, Jean-Emmanuel, additional, Provansal, Magali, additional, Namer, Moise, additional, Joly, Florence, additional, Pujade-Lauraine, Eric, additional, Grynberg, Michael, additional, Querleu, Denis, additional, Morice, Philippe, additional, Gompel, Anne, additional, and Ray-Coquard, Isabelle, additional

Published
2019
Full Text
View/download PDF

41. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer

Author

Cibula, David, primary, Pötter, Richard, additional, Planchamp, François, additional, Avall-Lundqvist, Elisabeth, additional, Fischerova, Daniela, additional, Haie-Meder, Christine, additional, Köhler, Christhardt, additional, Landoni, Fabio, additional, Lax, Sigurd, additional, Lindegaard, Jacob Christian, additional, Mahantshetty, Umesh, additional, Mathevet, Patrice, additional, McCluggage, W. Glenn, additional, McCormack, Mary, additional, Naik, Raj, additional, Nout, Remi, additional, Pignata, Sandro, additional, Ponce, Jordi, additional, Querleu, Denis, additional, Raspagliesi, Francesco, additional, Rodolakis, Alexandros, additional, Tamussino, Karl, additional, Wimberger, Pauline, additional, and Raspollini, Maria Rosaria, additional

Published
2018
Full Text
View/download PDF

42. Préservation de la fertilité, contraception et traitement hormonal de la ménopause chez les femmes traitées pour tumeurs malignes rares de l’ovaire : recommandations du réseau national dédié aux cancers gynécologiques rares (TMRG/GINECO)

Author

Rousset-Jablonski, Christine, primary, Selle, Fréderic, additional, Adda-Herzog, Elodie, additional, Planchamp, François, additional, Selleret, Lise, additional, Pomel, Christophe, additional, Chabbert-Buffet, Nathalie, additional, Daraï, Emile, additional, Pautier, Patricia, additional, Trémollières, Florence, additional, Guyon, Frederic, additional, Rouzier, Roman, additional, Laurence, Valérie, additional, Chopin, Nicolas, additional, Faure-Conter, Cécile, additional, Bentivegna, Enrica, additional, Vacher-Lavenu, Marie-Cécile, additional, Lhomme, Catherine, additional, Floquet, Anne, additional, Treilleux, Isabelle, additional, Lecuru, Fabrice, additional, Gouy, Sébastien, additional, Kalbacher, Elsa, additional, Genestie, Catherine, additional, de la Motte Rouge, Thibault, additional, Ferron, Gwenael, additional, Devouassoux-Shisheboran, Mojgan, additional, Kurtz, Jean-Emmanuel, additional, Namer, Moise, additional, Joly, Florence, additional, Pujade-Lauraine, Eric, additional, Grynberg, Michael, additional, Querleu, Denis, additional, Morice, Philippe, additional, Gompel, Anne, additional, and Ray-Coquard, Isabelle, additional

Published
2018
Full Text
View/download PDF

43. European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

Author

Oonk, Maaike H.M., primary, Planchamp, François, additional, Baldwin, Peter, additional, Bidzinski, Mariusz, additional, Brännström, Mats, additional, Landoni, Fabio, additional, Mahner, Sven, additional, Mahantshetty, Umesh, additional, Mirza, Mansoor, additional, Petersen, Cordula, additional, Querleu, Denis, additional, Regauer, Sigrid, additional, Rob, Lukas, additional, Rouzier, Roman, additional, Ulrikh, Elena, additional, van der Velden, Jacobus, additional, Vergote, Ignace, additional, Woelber, Linn, additional, and van der Zee, Ate G.J., additional

Published
2017
Full Text
View/download PDF

45. European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery

Author

Querleu, Denis, primary, Planchamp, François, additional, Chiva, Luis, additional, Fotopoulou, Christina, additional, Barton, Desmond, additional, Cibula, David, additional, Aletti, Giovanni, additional, Carinelli, Silvestro, additional, Creutzberg, Carien, additional, Davidson, Ben, additional, Harter, Philip, additional, Lundvall, Lene, additional, Marth, Christian, additional, Morice, Philippe, additional, Rafii, Arash, additional, Ray-Coquard, Isabelle, additional, Rockall, Andrea, additional, Sessa, Cristiana, additional, van der Zee, Ate, additional, Vergote, Ignace, additional, and du Bois, Andreas, additional

Published
2016
Full Text
View/download PDF

46. Traitements locorégionaux des sites métastatiques chez des patients atteints d’un mélanome pauci-métastatique (hors métastase cérébrale) : recommandations nationales françaises

Author

Sassolas, Bruno, primary, Mourrégot, Anne, additional, Thariat, Juliette, additional, Tiffet, Olivier, additional, Dygai-Cochet, Inna, additional, Mirabel, Xavier, additional, Truc, Gilles, additional, Cupissol, Didier, additional, Modiano, Philippe, additional, Combemale, Patrick, additional, Bedane, Christophe, additional, Derrey, Stéphane, additional, Lamant, Laurence, additional, Lubrano, Vincent, additional, Siegrist, Sophie, additional, Rougé-Bugat, Marie-Ève, additional, Mazeau-Woynar, Valérie, additional, Verdoni, Laëtitia, additional, Planchamp, François, additional, and Leccia, Marie-Thérèse, additional

Published
2014
Full Text
View/download PDF

47. Clinical Practice Guidelines for the Management of Patients With Endometrial Cancer in France

Author

Querleu, Denis, primary, Planchamp, François, additional, Narducci, Fabrice, additional, Morice, Philippe, additional, Joly, Florence, additional, Genestie, Catherine, additional, Haie-Meder, Christine, additional, Thomas, Laurence, additional, Quénel-Tueux, Nathalie, additional, Daraï, Emile, additional, Dorangeon, Pierre-Hervé, additional, Marret, Henri, additional, Taïeb, Sophie, additional, and Mazeau-Woynar, Valérie, additional

Published
2011
Full Text
View/download PDF

48. 2006 Monitoring Report: Clinical practice guidelines: the management of patients with carcinoma of unknown primary site

Author

Bugat, Roland, primary, Planchamp, François, additional, Lesimple, Thierry, additional, Voigt, Jean-Jacques, additional, Culine, Stéphane, additional, Lortholary, Alain, additional, Merrouche, Yacine, additional, Ganem, Gérard, additional, Kaminsky, Marie-Christine, additional, Négrier, Sylvie, additional, Pérol, Maurice, additional, Fizazi, Karim, additional, and Blot, Emmanuel, additional

Published
2007
Full Text
View/download PDF

49. [Management of the nodal disease in vulvar cancers. The ESGO guidelines].

Author

Querleu D, Rychlik A, Guyon F, Floquet A, and Planchamp F

Subjects
Female, Humans, Practice Guidelines as Topic, Lymphatic Metastasis therapy, Vulvar Neoplasms pathology, Vulvar Neoplasms therapy
Abstract

The European Society of Gynaecologic Oncology (ESGO) guidelines cover the whole field of common clinical situations in gynecologic oncology. Their elaboration follows a strict process including a systematic review of the literature, the setting up of a group of expert on the basis of scientific production, geographical balance, and multidisciplinarity, and an external review by users and patients. The recommendations for the management of vulvar cancer were elaborated in 2015 and published in 2017. They are available in open access on the ESGO website, and can be incorporated in clinical practice using the free ESGO guidelines smartphone application. This review is a selection of the sections addressing the diagnostic and strategical aspects of the management of lymph nodal disease in vulvar cancer. An additional review of the recent literature published since 2015 has been carried out. The management of nodal disease in vulvar cancer encompasses a diagnostic and a therapeutic component. Clinical and imaging assessment still play a major role, whilst the identification of the sentinel node is currently a mainstay of assessment of the nodal status in early vulvar cancer. The therapeutic component is based on the rational use of full lymph node dissection and (chemo)radiation., (Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)

Published
2020
Full Text
View/download PDF

50. [Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa].

Author

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, and Daraï E

Subjects
Antineoplastic Agents therapeutic use, Bevacizumab therapeutic use, Chemotherapy, Adjuvant, Female, France, Humans, Hyperthermia, Induced, Lymph Node Excision, Magnetic Resonance Imaging, Phthalazines therapeutic use, Piperazines therapeutic use, Societies, Medical, Ultrasonography, Carcinoma, Ovarian Epithelial diagnostic imaging, Carcinoma, Ovarian Epithelial drug therapy, Carcinoma, Ovarian Epithelial pathology, Carcinoma, Ovarian Epithelial surgery, Fallopian Tube Neoplasms diagnostic imaging, Fallopian Tube Neoplasms drug therapy, Fallopian Tube Neoplasms pathology, Fallopian Tube Neoplasms surgery, Ovarian Neoplasms diagnostic imaging, Ovarian Neoplasms drug therapy, Ovarian Neoplasms pathology, Ovarian Neoplasms surgery, Peritoneal Neoplasms diagnostic imaging, Peritoneal Neoplasms drug therapy, Peritoneal Neoplasms pathology, Peritoneal Neoplasms surgery
Abstract

Faced to an undetermined ovarian mass on ultrasound, an MRI is recommended and the ROMA score (combining CA125 and HE4) can be proposed (grade A). In case of suspected early stage ovarian or fallopian tube cancer, omentectomy (at least infracolonic), appendectomy, multiple peritoneal biopsies, peritoneal cytology (grade C) and pelvic and para-aortic lymphadenectomy are recommended (grade B) for all histological types, except for the expansive mucinous subtype where lymphadenectomy may be omitted (grade C). Minimally invasive surgery is recommended for early stage ovarian cancer, if there is no risk of tumor rupture (grade B). Adjuvant chemotherapy with carboplatin and paclitaxel is recommended for all high-grade ovarian or Fallopian tube cancers, stage FIGO I-IIA (grade A). In case of ovarian, Fallopian tube or primitive peritoneal cancer of FIGO III-IV stages, thoraco-abdomino-pelvic CT scan with injection (grade B) is recommended. Laparoscopic exploration for multiple biopsies (grade A) and to evaluate carcinomatosis score (at least using the Fagotti score) (grade C) are recommended to estimate the possibility of a complete surgery (i.e. no macroscopic residue). Complete medial laparotomy surgery is recommended for advanced cancers (grade B). It is recommended in advanced cancers to perform para-aortic and pelvic lymphadenectomy in case of clinical or radiological suspicion of metastatic lymph node (grade B). In the absence of clinical or radiological lymphadenopathy and in case of complete peritoneal surgery during an initial surgery for advanced cancer, it is possible not to perform a lymphadenectomy because it does not modify the medical treatment and the overall survival (grade B). Primary surgery is recommended when no tumor residue is possible (grade B). After a complete first surgery, it is recommended to deliver 6 cycles of intravenous (grade A) or to propose intraperitoneal (grade B) chemotherapy, to be discussed with patient, according to the benefit/risk ratio. After a complete interval surgery for a FIGO III stage, the hyperthermic intra peritoneal chemotherapy (HIPEC) can be proposed in the same conditions of the OV-HIPEC trial (grade B). In case of tumor residue after surgery or FIGO stage IV, chemotherapy associated with bevacizumab is recommended (grade A)., (Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results